Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2026-06-26 @ 5:09 AM
Study NCT ID:
NCT01496534
Status:
TERMINATED
Last Update Posted:
2013-11-27
First Post:
2011-12-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid Tumors
Sponsor:
Matthew Galsky
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GCO 11-0946
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |